Potential Biomarker for Human Uterine Leiomyosarcoma
Abstract
N/A
J Clin Med Res. 2014;6(5):392-394
doi: http://dx.doi.org/10.14740/jocmr1867e
J Clin Med Res. 2014;6(5):392-394
doi: http://dx.doi.org/10.14740/jocmr1867e
User
|
MOST READ |
(For the last 12-month published articles)
Article Tools
Email this article (Login required)
Email this article (Login required) |
INDEXED IN |
|
|
|
|
| Scopus |
|
QUICK LINKS |
|
|
|
|
|
|
Submit Manuscript |
|
|
Editorial Board |
|
|
|
|
|
|
|
|
|
|
|
Conflict of Interest |
|
|
|
|
|
|
|
|
|
|
ARTICLE STATISTICS |
|
Submission to First Decision |
|
22 Days |
|
Acceptance Rate |
|
27% |
|
Acceptance to Publication |
|
18 Days |
|
*Average article statistics from the last 12 months data |
|
COVID-19 RESEARCH |
|
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers, the post COVID-19 condition (or long COVID) includes long term symptoms which may persist for months or years after SARS-CoV-2 infection. We will consider submissions related to all aspects of COVID-19 and Long COVID, and process the manuscripts in priority. |
